SCHEMBL14934810

SCHEMBL14934810

N#CCCCCC(=O)Nc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 17/20 0.64
HDAC1 Q13547 17/20 0.64
HDAC7 Q8WUI4 17/20 0.64
HDAC11 Q96DB2 17/20 0.64
HDAC8 Q9BY41 17/20 0.64
HDAC6 Q9UBN7 17/20 0.64
HDAC9 Q9UKV0 17/20 0.64
HDAC5 Q9UQL6 17/20 0.64
HDAC3 O15379 16/20 0.64
HDAC2 Q92769 16/20 0.64
HDAC10 Q969S8 16/20 0.64
CYP3A4 P08684 2/20 0.64
CYP1A2 P05177 1/20 0.64
CYP2D6 P10635 1/20 0.64
NCOR1 O75376 2/20 0.63
NCOR2 Q9Y618 2/20 0.63
KDM4E B2RXH2 1/20 0.63
BRD4 O60885 1/20 0.63
NR1I2 O75469 1/20 0.63
EGFR P00533 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14934830 0.98 HDAC4 (0.67) HDAC4HDAC1HDAC7HDAC11HDAC8
SCHEMBL14934838 0.98 HDAC4 (0.67) HDAC4HDAC1HDAC7HDAC11HDAC8
SCHEMBL14934660 0.98 HDAC4 (0.67) HDAC4HDAC1HDAC7HDAC11HDAC8
SCHEMBL11162134 0.95 CYP3A4 (0.71) HDAC4HDAC1HDAC7HDAC11HDAC8
SCHEMBL517309 0.86 HDAC4 (0.81) HDAC4HDAC1HDAC7HDAC11HDAC8
SCHEMBL15675744 0.85 CYP3A4 (0.66) HDAC4HDAC1HDAC7HDAC11HDAC8
SCHEMBL1065393 0.84 HDAC4 (0.85) HDAC4HDAC1HDAC7HDAC11HDAC8
SCHEMBL137348 0.84 HDAC4 (0.85) HDAC4HDAC1HDAC7HDAC11HDAC8
SCHEMBL6669511 0.84 HDAC4 (0.85) HDAC4HDAC1HDAC7HDAC11HDAC8
SCHEMBL6665592 0.84 HDAC4 (0.85) HDAC4HDAC1HDAC7HDAC11HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013066836-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2013-05-10 WO disclosed